Why it was recalled
Lack of Assurance of Sterility
Product description
Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083
Lot numbers, UPCs & expiration codes
All lots within expiry
Where it was sold
nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0463-2022
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Dec 21, 2021
- FDA report date
- Feb 9, 2022
- Quantity
- 57,994 vials
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy
Original FDA data
Every field from FDA enforcement report D-0463-2022, exactly as published.
Show all FDA fields
- City
- Union
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 89270
- Address
- 2333 Morris Ave Ste B101
- Code information
- All lots within expiry
- Postal code
- 07083-5716
- Report date
- Feb 9, 2022
- Product type
- Drugs
- Recall number
- D-0463-2022
- Classification
- Class II
- Recalling firm
- Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy
- Product quantity
- 57,994 vials
- Reason for recall
- Lack of Assurance of Sterility
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083
- Distribution pattern
- nationwide in the USA
- Recall initiation date
- Dec 21, 2021
- Initial firm notification
- Letter
- Center classification date
- Jan 31, 2022